These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 758920)

  • 1. PHA-induced cellular cytotoxicity. Inhibition by a nonimmunoglobulin factor present in sera from patients with active systemic lupus erythematosus.
    Ruíz-Argüelles A; Díaz-Jouanen E; Alarcón-Segovia D
    Arthritis Rheum; 1979 Jan; 22(1):59-65. PubMed ID: 758920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic lupus erythematosus.
    Wright JK; Hughes P; Gelsthorpe K; Ward AM; Rowell NR
    Ann Rheum Dis; 1981 Feb; 40(1):11-7. PubMed ID: 6970550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of mitogenic responses of mononuclear cells by anti-ds DNA antibodies resembling immune disorders in patients with systemic lupus erythematosus.
    Yu CL; Chang KL; Chiu CC; Chiang BN; Han SH; Wang SR
    Scand J Rheumatol; 1989; 18(5):265-76. PubMed ID: 2595347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders.
    Williams RC; Lies RB; Messner RP
    Arthritis Rheum; 1973; 16(5):597-605. PubMed ID: 4270279
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte-reactive antibodies in patients with systemic lupus erythematosus.
    Arend WP; Emmerich TE; Sturge JC; Starkebaum GA
    Arthritis Rheum; 1977 Jun; 20(5):1049-57. PubMed ID: 68777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG anti-gamma-globulin factor in rheumatoid arthritis sera detected by mixed agglutination test.
    Kasukawa R; Sato M; Yoshida H; Yoshida T
    Int Arch Allergy Appl Immunol; 1977; 54(3):247-54. PubMed ID: 873623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Diaz-Jouanen E; Bankhurst AD; Williams RC
    Arthritis Rheum; 1976; 19(2):133-41. PubMed ID: 1083239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
    Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
    Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of interleukin-2 on peripheral lymphocytes and monocytes. III. Proliferative and cytotoxic effects in vitro in patients with systemic erythematosus and progressive polyarthritis].
    Jíra M; Strejcek J; Zavadil Z; Antosová E; Rejholec V
    Cas Lek Cesk; 1988 Dec; 127(52):1609-12. PubMed ID: 3265892
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.
    Yamada A; Winfield JB
    J Clin Invest; 1984 Dec; 74(6):1948-60. PubMed ID: 6210306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of histamine on PHA chemiluminescence response of blood mononuclear cells in autoimmune patients.
    Meretey K; Bohm U; Falus A
    Agents Actions; 1986 Apr; 18(1-2):254-7. PubMed ID: 3728210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    Sagawa A; Abdou NI
    J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed T cell colony growth in systemic lupus erythematosus.
    Bernstein ML; Winkelstein A; Dobson SA
    Arthritis Rheum; 1980 Apr; 23(4):385-91. PubMed ID: 6966151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient gamma-interferon production in patients with systemic lupus erythematosus.
    Tsokos GC; Boumpas DT; Smith PL; Djeu JY; Balow JE; Rook AH
    Arthritis Rheum; 1986 Oct; 29(10):1210-5. PubMed ID: 2429672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.